Study on the interleukin-1 signaling

IL-1信号传导研究

基本信息

  • 批准号:
    06672194
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

The mechanisms of IL-latiproliferative effect and the acquired resistance to IL-1 effect were studied using human melanoma cells A375. As type I IL-1 receptor (IL-1R) transduces IL-1 signal, the regulatory mechanisms of IL-1R expression in vitro and in vivo were also studied.1. The mechanism of IL-1 antiproliferative effectIL-1R cDNA was transfected into A375-5 which is resistant to IL-1 because it expresses very low number of IL-1R.We obtained the transfectant which became sensitive to IL-1. Using this clone we studied the IL-1 signaling. IL-1 downregulated ODC activity. Although ODC mRNA level was not changed, the amount of protein of ODC decreased. The mRNA of antizyme (AZ), a proteinous factor which inactivates ODC by binding to ODC and causes degradation of ODC,was upregulated by IL-1. Furthermore, antisense of AZ inhibited IL-1 effects. Terefore, AZ induced by IL-1 appeared to be important in the IL-1 signaling.2. The mechanism of acquired resistance to IL-1Using the cells which acquired resistance to IL-1 antiproliferative effect after long period of culture, we studied the mechanism. Expression vectors of IL-1alpha sense and IL-1alpha antisense were transfected into IL-1 sensitive and resistant cells, respectively. However, the sensitivity of the transfectants to IL-1 was not changed. Therefore, expression of IL-1alpha appeared not to be sufficient to the resistance.3. Regulation of IL-1R expressionUsing human fibroblast cell line TIG-1, we studied the regulatory mechanism of type I IL-1R wxpression. Tyrosine kinase appeared to play an important role in constitutive expression of IL-1R.Whtn mice were injected with LPS,a marked increase of IL-1R mRNA was induced in the liver. The upregulation apperaed to be induced by the endogenously produced IL-1 and IL-6.
以人黑色素瘤细胞A375为研究对象,研究了IL-1促增殖作用和获得性抵抗IL-1作用的机制。由于IL-1受体(IL-1R)是IL-1信号的转导通路,本研究还对IL-1R在体内外表达的调控机制进行了研究。IL-1R的抗增殖作用机制将IL-1R基因导入对IL-1产生抗性的A375-5细胞,获得对IL-1敏感的A375-5。利用该克隆,我们研究了IL-1信号转导途径。IL-1下调ODC活性。虽然ODC的mRNA水平没有变化,但ODC的蛋白质含量减少。抗酶(AZ)是一种蛋白因子,通过与ODC结合而使ODC失活,导致ODC降解,IL-1上调了AZ的表达。此外,反义AZ可抑制IL-1的作用。因此,IL-1诱导的AZ似乎在IL-1信号转导中起重要作用。IL-1获得性耐药的机制利用长期培养获得IL-1耐药细胞的抗增殖作用,探讨其机制。IL-1α正义表达载体和IL-1α反义表达载体分别导入IL-1敏感和耐药细胞。但转基因细胞对IL-1的敏感性没有改变。因此,IL-1α的表达似乎不足以抵抗。利用人成纤维细胞系TIG-1,研究了I型IL-1R表达的调控机制。酪氨酸激酶在IL-1R的组成性表达中起重要作用。这种上调可能是由内源性产生的IL-1和IL-6诱导的。

项目成果

期刊论文数量(46)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
D. Yang, T. Takii, H. Hayashi S. Ito, M. Hayashi & K. Onozaki: "Molecular cloning of human antizyml cDNA" Biochemistry and Molecular Biology International. (in press). (1996)
D. Yang、T. Takii、H. Hayashi S. Ito、M. Hayashi
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Ito, H.Hayashi, N.Watanabe, Y.Kobayashi, T.Takii and K.Onozaki: "Interleukin 1 (IL-1) production is not essential for acquired resistance of human melanoma cells A375 to anti-proliferative effect of IL-1." Int.J.Cancer. (in press). (1996)
S.Ito、H.Hayashi、N.Watanabe、Y.Kobayashi、T.Takii 和 K.Onozaki:“白细胞介素 1 (IL-1) 的产生对于人黑色素瘤细胞 A375 的抗增殖作用的获得性抵抗并不重要。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Takii,K.Wada,T.Chiba,H.Hayashi,T.Ishihara,K.Onzaki: "Development of glycosylated human IL-1α,neoglyco IL-1α,coupled caith D-mannose demier;Synthesis and biologcal activities in vitro." LYMPHOKINE AND CYTOKINE RESEARCH. 13. 265-270 (1994)
Y. Takii、K. Wada、T. Chiba、H. Hayashi、T. Ishihara、K. Onzaki:“糖基化人 IL-1α、新糖 IL-1α、偶联 caith D-甘露糖二聚体的开发;合成和生物活性淋巴细胞因子和细胞因子研究 13. 265-270 (1994)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Wada,T.Chiba,Y.Takei,H.Ishihara,H.Hayashi,K.Onzaki: "Synthes is of immunosuppressive neoglycoproteins:Bovine serum albumin coupled with 8(hydrazino-carbnoyl)octyl4-or6-0-α-D.Man-α-D-Man." Journal of CARBOHYDRATE CHEMISTRY. 13. 941-965 (1994)
K. Wada、T. Chiba、Y. Takei、H. Ishihara、H. Hayashi、K. Onzaki:“合成免疫抑制性新糖蛋白:牛血清白蛋白与 8(肼基-羰酰基)辛基 4-或 6-0-α- 偶联D.Man-α-D-Man。”《碳水化合物化学杂志》。13. 941-965 (1994)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ONOZAKI Kikuo其他文献

ONOZAKI Kikuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ONOZAKI Kikuo', 18)}}的其他基金

Regulatory mechanism of the induction and function of IL-1
IL-1诱导和功能的调控机制
  • 批准号:
    20590064
  • 财政年份:
    2008
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on the action mechanism of IL-1 and its regulation
IL-1作用机制及其调控研究
  • 批准号:
    14370750
  • 财政年份:
    2002
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The mechanism and its regulation of interleukin 1 biological activities
白细胞介素1生物活性的机制及其调控
  • 批准号:
    11470487
  • 财政年份:
    1999
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on interleukin 1 signal transduction
白细胞介素1信号转导研究
  • 批准号:
    08457614
  • 财政年份:
    1996
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of IL-1 with selective activities by introduction of carbohydrates
通过引入碳水化合物开发具有选择性活性的 IL-1
  • 批准号:
    07557159
  • 财政年份:
    1995
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
The mechanism of the acquired resistance to the anti-proliferative effect of IL-1 on human melanoma cells.
IL-1对人黑色素瘤细胞的抗增殖作用获得性抵抗的机制。
  • 批准号:
    04671364
  • 财政年份:
    1992
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Study on the Interleukin 1 Growth-Regulatory Activity.
白细胞介素1生长调节活性的研究。
  • 批准号:
    01571233
  • 财政年份:
    1989
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

相似海外基金

Interleukin-1 Receptor Modulating Therapy for Treating Macular Degeneration
用于治疗黄斑变性的 IL-1 受体调节疗法
  • 批准号:
    478746
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Operating Grants
Investigating the neuroprotective potential of interleukin-1 receptor antagonist (IL-1Ra) after soman exposure
研究梭曼暴露后白细胞介素 1 受体拮抗剂 (IL-1Ra) 的神经保护潜力
  • 批准号:
    NE/V019848/1
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Research Grant
Role of Interleukin-1 Receptor Clustering in Neuropathic Pain Signaling
IL-1 受体簇在神经病理性疼痛信号转导中的作用
  • 批准号:
    10043097
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
The interleukin-1 receptor regulates crosstalk between myeloid and renal tubular cells in hypertension
IL-1 受体调节高血压中骨髓细胞和肾小管细胞之间的串扰
  • 批准号:
    10361423
  • 财政年份:
    2019
  • 资助金额:
    $ 1.34万
  • 项目类别:
Targeting the interleukin-1 receptor for treating ischemic eye diseases
靶向白介素 1 受体治疗缺血性眼病
  • 批准号:
    493638-2016
  • 财政年份:
    2017
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Collaborative Health Research Projects
Regulation of expression and mechanism of secretion of the Toll/Interleukin-1 receptor protein C of uropathogenic E. coli
尿路致病性大肠杆菌Toll/Interleukin-1受体蛋白C的表达调控及分泌机制
  • 批准号:
    363882874
  • 财政年份:
    2017
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Research Grants
Inhibiting Interleukin-1 receptor during pregnancy to prevent neonatal mortality and morbidity induced by placental/chorioamniotic inflammation
妊娠期间抑制白介素 1 受体可预防胎盘/绒毛膜羊膜炎症引起的新生儿死亡和发病
  • 批准号:
    347896
  • 财政年份:
    2015
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Studentship Programs
Inhibiting Interleukin-1 receptor during pregnancy to prevent neonatal mortality and morbidity induced by placental/chorioamniotic inflammation
妊娠期间抑制白介素 1 受体可预防胎盘/绒毛膜羊膜炎症引起的新生儿死亡和发病
  • 批准号:
    339562
  • 财政年份:
    2015
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Studentship Programs
The role of natural interleukin-1 receptor antagonist in amyloid-induced Fas-mediated beta-cell death
天然白细胞介素 1 受体拮抗剂在淀粉样蛋白诱导的 Fas 介导的 β 细胞死亡中的作用
  • 批准号:
    349985
  • 财政年份:
    2015
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Studentship Programs
Interleukin-1 Receptor Antagonist in ARDS
ARDS 中的 IL-1 受体拮抗剂
  • 批准号:
    9130417
  • 财政年份:
    2015
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了